Endocrinology, Vol 129, 421-428, Copyright © 1991 by Endocrine Society

ARTICLES

The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84)

L Mosekilde, CH Sogaard, CC Danielsen and O Torring
Department of Connective Tissue Biology, University of Aarhus, Denmark.

PTH has a proven anabolic effect on bone mass, as has been shown in several animal models and treatment regimens. The aim of this study was to ascertain whether the positive effect on bone mass is also reflected in the quality of bone formed. The study was performed in a rat model using human PTH (hPTH). One hundred and twenty male Wistar rats, divided into 10 groups, were given either hPTH-(1-34) or hPTH-(1-84) in daily sc doses. Dose levels ranged from 0.11-3.00 nmol/100 g BW.day for a period of 30 days. At death all six lumbar vertebrae were obtained from each rat. A combination of methods was applied to these vertebral bodies in order to ascertain the effect of hPTH on vertebral bone volume, density, trabecular structure, and biomechanical competence. The results revealed a dose-dependent increase in total volume, dry weight, ash weight, and trabecular bone volume. Also, a dose-dependent increase in load values could be demonstrated. The increase in bone strength remained significant after normalization for both cross- sectional area and bone mass. This indicates that the increase in bone size and bone mass was not achieved at the expense of the quality of the bone present. When the two treatments were administered at the same molar dose level, no difference between hPTH-(1-34) and hPTH-(1-84) was revealed. On the basis of this study, it is concluded that PTH could prove to be a promising treatment in the management of osteopenic states.

This article has been cited by other articles:

				S. P Shrader and K. R Ragucci Parathyroid Hormone (1-84) and Treatment of Osteoporosis Ann. Pharmacother., September 1, 2005; 39(9): 1511 - 1516. [Abstract] [Full Text] [PDF]

				T. M. Murray, L. G. Rao, P. Divieti, and F. R. Bringhurst Parathyroid Hormone Secretion and Action: Evidence for Discrete Receptors for the Carboxyl-Terminal Region and Related Biological Actions of Carboxyl- Terminal Ligands Endocr. Rev., February 1, 2005; 26(1): 78 - 113. [Abstract] [Full Text] [PDF]

				J. L. Vahle, G. G. Long, G. Sandusky, M. Westmore, Y. L. Ma, and M. Sato Bone Neoplasms in F344 Rats Given Teriparatide [rhPTH(1-34)] Are Dependent on Duration of Treatment and Dose Toxicol Pathol, June 1, 2004; 32(4): 426 - 438. [Abstract] [PDF]

				A. B. Hodsman, D. A. Hanley, M. P. Ettinger, M. A. Bolognese, J. Fox, A. J. Metcalfe, and R. Lindsay Efficacy and Safety of Human Parathyroid Hormone-(1-84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5212 - 5220. [Abstract] [Full Text] [PDF]

				M. Sato, J. Vahle, A. Schmidt, M. Westmore, S. Smith, E. Rowley, and L. Y. Ma Abnormal Bone Architecture and Biomechanical Properties with Near-Lifetime Treatment of Rats with PTH Endocrinology, September 1, 2002; 143(9): 3230 - 3242. [Abstract] [Full Text] [PDF]

				M. Sato, Y. L. Ma, J. M. Hock, M. S. Westmore, J. Vahle, A. Villanueva, and C. H. Turner Skeletal Efficacy with Parathyroid Hormone in Rats Was Not Entirely Beneficial with Long-Term Treatment J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 304 - 313. [Abstract] [Full Text] [PDF]

				M. Sato, G. Q. Zeng, and C. H. Turner Biosynthetic Human Parathyroid Hormone (1-34) Effects on Bone Quality in Aged Ovariectomized Rats Endocrinology, October 1, 1997; 138(10): 4330 - 4337. [Abstract] [Full Text] [PDF]

				A. Toromanoff, P. Ammann, L. Mosekilde, J. S. Thomsen, and J.-L. Riond Parathyroid Hormone Increases Bone Formation and Improves Mineral Balance in Vitamin D-Deficient Female Rats Endocrinology, June 1, 1997; 138(6): 2449 - 2457. [Abstract] [Full Text] [PDF]

				L. Jin, S. L. Briggs, S. Chandrasekhar, N. Y. Chirgadze, D. K. Clawson, R. W. Schevitz, D. L. Smiley, A. H. Tashjian, and F. Zhang Crystal Structure of Human Parathyroid Hormone 1-34 at 0.9-A Resolution J. Biol. Chem., August 25, 2000; 275(35): 27238 - 27244. [Abstract] [Full Text] [PDF]